美股異動丨匯豐盤前升約2.5% 首季加上特別股息共派息31美分
匯豐控股(HSBC.US)美股盤前升約2.5%,報43.23美元。H股盤中一度高見67.05港元,逼近2018年1月創下歷史新高67.605港元。
匯豐今日公佈2024年第一季業績,收入208億美元,同比增長3%;除税前利潤126.5億美元,高於市場預估的126.1億美元。董事會已通過派發第一次股息每股0.1美元。此外,於完成出售加拿大銀行業務後,董事會已批准派發每股0.21美元特別股息,將於6月與第一次股息一同派付。匯豐完成發佈2023年全年業績時宣佈的20億美元回購之後,現擬展開最多達30億美元的股份回購。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.